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Abstract
Background: Quorum sensing is a term that describes an environmental sensing system that allows bacteria to monitor
their own population density which contributes significantly to the size and development of the biofilm. Many gram
negative bacteria use N-acyl-homoserine lactones as quorum sensing signal molecules. In this study, we sought to find out if
the biofilm formation among clinical isolates of Acinetobacter spp. is under the control of autoinducing quorum sensing
molecules.
Methodology/Principal Findings: Biofilm formation among clinical isolates of Acinetobacter spp. was assessed and the
production of signal molecules were detected with Chromobacterium violaceum CV026 biosensor system. Characterisation
of autoinducers was carried out by mass spectrometric analysis. We have also reported the identification of an autoinducer
synthase gene, abaI among the isolates that produce quorum sensing signal molecules and have reported that the
mutation in the abaI gene influences their biofilm forming capabilities. Using a microtitre-plate assay it was shown that 60%
of the 50 Acinetobacter spp. isolates significantly formed biofilms. Further detection with the biosensor strain showed that
some of these isolates produced long chain signal molecules. Mass spectrometric analysis revealed that five of these isolates
produced N-decanoyl homoserine lactone and two isolates produced acyl-homoserine lactone with a chain length equal to
C12. The abaI gene was identified and a tetracycline mutant of the abaI gene was created and the inhibition in biofilm
formation in the mutant was shown.
Conclusions/Significance: These data are of great significance as the signal molecules aid in biofilm formation which in turn
confer various properties of pathogenicity to the clinical isolates including drug resistance. The use of quorum sensing
signal blockers to attenuate bacterial pathogenicity is therefore highly attractive, particularly with respect to the emergence
of multi antibiotic resistant bacteria.
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Introduction
Acinetobacter spp. are gram negative aerobic coccobacilli that are
ubiquitous in nature, persistent in the hospital environment, and
cause a variety of opportunistic nosocomial infections [1]. Among
the Acinetobacter genomic species, Acinetobacter baumannii is recog-
nized as the species most frequently isolated from patients.
Acinetobacter spp. have been isolated from various types of
opportunistic infections, including septicemia, pneumonia, endo-
carditis, meningitis, skin and wound infection, and urinary tract
infection [1]. The distribution by site of Acinetobacter infection does
not differ from that of other nosocomial Gram-negative bacteria.
Often, Acinetobacter spp. emerged as important pathogens in the
intensive care unit (ICU) setting, and this is probably due to the
increasingly invasive diagnostic and therapeutic procedures used
in hospital ICUs [2]. As it is a multi-drug resistant organism,
infections are difficult to treat [3], resulting in mortalities of 23%
for hospitalised patients and 43% for patients under intensive care
[4]. The Antimicrobial Availability Task Force of the infectious
Diseases Society of America recently identified A. baumannii, along
with Aspergillus spp., extended–spectrum b-lactamase producing
Enterobacteriaceae, Vancomycin-resistant Enterococcus faecium, Pseudo-
monas aeruginosa and methicillin-resistant Staphylococcus aureus, as
‘particularly problematic pathogens’ for which there is a desperate
need for new drug development [5]. Similarly, the SENTRY
Antimicrobial Surveillance Program lists Acinetobacter spp. as the
causative agent in 2.3 to 3.0% of health care-associated
pneumonia and as the eighth most common pathogen (4.0%)
isolated from ICU patients worldwide [6]. Thus, Acinetobacter spp.
is emerging as an increasingly important multidrug resistant
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pathogen, spreading in hospitals, and causing severe adverse
outcomes. Besides that, Acinetobacter spp. seems to be spreading
from hospital to hospital, and it has caused endemic infections in
various geographical areas through multiple hospital outbreaks. It
has become a leading nosocomial pathogen in many hospitals as
compared to other non-fermenting Gram-negative bacilli. There-
fore, a new strategy in the successful treatment of Acinetobacter
infections is an absolute necessity.
Most Acinetobacter spp. research to date has focused on
cataloguing and understanding the variety of antimicrobial
resistance genes and mechanisms found within the species
[7,8,9,10]. It has been shown that A. baumannii forms biofilm with
enhanced antibiotic resistance [11,12]. Biofilm formation is a trait
closely related to pathogenicity. Bacteria form multicellular biofilm
communities on most surfaces. Formation of these sessile
communities and their inherent resistance to antimicrobial agents
are at the root of many persistent and chronic bacterial infections.
Biofilms represent microbial societies with their own defense and
communication systems. According to a public announcement
from the US National Institutes of Health more than 80% of all
microbial infections involve biofilms [13,14].
Very little is known regarding factors required for biofilm
formation in A. baumannii. A chaperone and a protein that are
required for this process has been identified [15,16]. The
expression of an operon, pgaABCD, encoding a poly N-acetyl
glucosamine (PGA) extracellular matrix has been shown to have a
role in biofilm formation [17,18].
There are reports suggesting that the autoinducer (AI), quorum
sensing (QS) signal molecules play an important role in biofilm
formation [19,20]. Studies on two fundamental bacterial small-
molecule signaling pathways: extracellular quorum-sensing signal-
ing and intracellular cyclic dinucleotide signalling suggested how
these two pathways may converge to control complex processes
including multicellularity, biofilm formation, and virulence [19].
Cell-to-cell signalling is often mediated by the production of
N-acyl-homoserine lactone (AHL) signalling molecules [21].
These are synthesized by the family of homologue proteins.
They use the appropriately charged acyl carrier protein as the
major acyl chain donor and S-adenosyl methionine, which
provides the homoserine moiety [22]. To detect these signals,
various biosensor strains have been constructed [23,24,25].
These biosensors have been used previously to show AHL
productions in Acinetobacter spp. By using an Agrobacterium
tumefaciens reporter strain it was shown that all the cultures
produced two to four detectable signal molecules with different
chromatographic patterns. In A. calcoaceticus BD413 supernatants
four compounds were detected in a time-dependent manner,
and maximal activity was reached at stationary phase [26].
There is a previous report on the AHLs produced by
Acinetobacter baumanii and it has been shown that mutations in
autoinducer synthesis lead to the formation of biofilms with
abnormal structures in Acinetobacter baumannii [27].
In this study, we report the detection of AHL signal molecules
among the 50 biofilm forming clinical isolates of Acinetobacter spp.
from University of Malaya Medical Centre, Malaysia using the
Chromobacterium violaceum CV026 biosensor monitor system. Mass
spectrometry was used to identify the AHL signals produced by
these isolates. An autoinducer synthase designated abaI has also
been identified among these clinical isolates producing QS signal
molecules, a mutant of this gene has been created and has been
shown to influence the biofilm forming capabilities. The impair-
ment in the biofilm formation was rescued by ethyl acetate extracts
of the culture supernatants from the wildtype strain. These
findings could allow further investigations into the antagonists of
the QS signal molecules, which could inhibit biofilm formation
among the clinical pathogens.
Results
Quantification of Biofilm Formation Using Microtiter
Plate Method
Quantification of biofilm produced by the 50 clinical isolates of
Acinetobacter spp. revealed that 30(60%) isolates significantly formed
biofilms under prolonged period of incubation (p value ,0.05).
Figure 1 shows the graphical representation of the biofilm
formation among all the 50 isolates. Quantification of biofilm
formation after prolonged incubation periods showed that in all
the 50 isolates 48 hrs incubation showed higher biofilm formation
compared to 24 hrs of incubation (Fig. 1). Isolates with no change
in OD over the control were classified as non-biofilm formers. The
microtitre plate assay was done in triplicates and the data were
pooled from these experiments. Thus the graph also shows the
standard deviation.
Screening for AHLs Among the Isolates
When CV026 induction test was carried out for the detection of
short chain AHLs, all the 50 isolates produced colourless colonies.
This showed that none of these Acinetobacter spp. clinical isolates
produced short chain AHL molecules. In CV026 inhibition test, 7
of the isolates marked as S1, S11, S53, S54, S93, S102, S117 tested
positive for long- chain AHL production. They produced colour-
less colonies in the induced chromoplate, while the negative
isolates produced purple colonies (Fig. 2). The CV026 induction
test was done on the chromoplate and the positive colonies
producing the AHLs are expected to produce purple colonies.
None of the tested isolates were positive for the induction test.
CV026 inhibition test was carried in a chromoplate to which the
synthetic AHL was previously added. Here long-chain AHLs are
expected to inhibit the induced CV026 and thus produce
colourless colonies in the purple background. Seven isolates tested
positive for long-chain AHLs.
Quantification of the AHLs by Well-diffusion Assay
AHLs were extracted and quantified by the well diffusion
assay. Increasing amounts of AHL added to the wells in the
well-diffusion assay caused increase in the size of induced and
inhibited zones surrounding the wells in Chromobacterium violaceum
CV026 (Fig. 3A). Standard curves were created by comparing
log (amount of AHL) to surface area of the zones (Fig. 3A).
Based on the standard curves, extraction efficiencies were
calculated using DHL (Decanyl Homoserine Lactone) in case of
long-chain AHLs and HHL (3-N-Hexanoyl homoserine lactone)
in case of short-chain AHLs, using both acidified and non-
acidified ethyl acetate. Approximately twice as much AHL was
extracted when using acidified ethyl acetate as compared to
non-acidified. Extraction efficiencies were tested on supernatants
from Acinetobacter strains and it was observed that acidified
extractions gave better yields as compared to the non-acidified
extractions. Yields obtained were in the range of 161029 moles
to 661029 moles of AHLs (Fig. 3B). These were later confirmed
by quantification through mass spectrometry.
Mass Spectrometry and Structural Identification of the
AHLs
Mass spectrometric analysis revealed the presence of C10 AHLs
in the tested 5 isolates (S1, S11, S54, S93 and S117) and other 2
isolates (S53, S102) produced AHLs with chain lengths C12. Of the
QS Signal Molecules Among Clinical Isolates
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masses that were reported the only ones that seem to make sense
are 284 and 282 as an AHL with a 12 carbon acyl chain, with the
lower mass (282) containing a single alkene (Table 1). An alkene
could be anywhere along the chain length, however it can be
rationalized that it could be a dehydration product from a beta-
hydroxy derivative. The retention time at a later time than the
decanoyl standard fits well. These masses were found in samples
53 and 102, which well confirms the presence of chain lengths C12.
The TIC trace of each sample (1, 11, 53, 54, 93, 102, 117) with
overlaid common precursor ions are shown in Fig. 4.
Identification of abaI Gene in Acinetobacter spp.
Producing the QS Signal Molecules
Polymerase Chain Reaction (PCR) for abaI gene, produced
amplicons of 382 bp in all the 7 isolates (isolate no.S1, S11, S53,
S54, S93, S102, S117) which produced the QS signal molecules.
The electrophoretic banding patterns are shown (Fig. 5).
Organisation of the abaI Region in Acinetobacter spp.
(S117)
The amplicon of the abaI gene from isolate S117 was further
sequenced and analysed. Isolate S117 showed the maximum
differences in the nucleotides and thus the aminoacid sequence of
the autoinducer synthase protein when compared with the already
reported abaI gene sequences. Hence this protein was chosen for
all subsequent experiments. The BLAST analysis program
revealed that the abaI gene identified in Acinetobacter spp. isolate
S117 is 92% identical to the corresponding protein reported in
recently published A. baumannii ATCC 17978 genome [28]. The
AbaI protein shared 91% identity and 97% similarity with the
already reported AbaI protein of A. baumannii M2 strain [27].
Further, the BLAST analysis also revealed that the AbaI protein
exhibited 61% identity and 79% similarity to the acyl homoserine
lactone synthase of Halothiobacillus neapolitanus c2, 65% identity and
75% similarity to the autoinducer synthesis protein of Acidithioba-
cillus ferrooxidans ATCC 53993, 47% identity and 67% similarity
with autoinducer synthatase family protein of Burkholderia mallei
Figure 1. Biofilm formation among the 50 isolates of Acinetobacter spp. in microtiter plates. Strain numbers are designated in x axis.
About 60% of the isolates significantly forms biofilms when incubated for prolonged hours. Data are pooled from triplicate experiments. The results
are expressed as the mean and the error bars indicate the standard deviation. The P value was less than 0.05 (P,0.05).
doi:10.1371/journal.pone.0036696.g001
QS Signal Molecules Among Clinical Isolates
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e36696
ATCC 23344 and 49% identity and 63% similarity with N-acyl
homoserine lactone synthase from Pseudomonas fluorescens. This
sequence has already been submitted to the NCBI Genbank
(Accession number HQ013310).
Mutation in the abaI Gene
The abaI gene from isolate S117 cloned into plasmid vector
pCR 2.1-TOPO and transformed into chemically competenet
E.coli cells. These cells carrying the wild type abaI gene was found
to produce the same kind of AHL signal produced by S117 in the
thin layer chromatography bioassay overlay (results not shown).
The abaI::Tc mutant was further constructed which failed to
produce any detectable signals using the biosensor strain (results
not shown). The examination of the ability of the wild type and the
abaI::Tc mutant to form biofilms showed that there was inhibition
in the biofilm formation in the abaI::Tc mutant when compared to
the wild type (Fig. 6A). The mutation complementation experi-
ment with the ethyl-acetate extracts of the culture supernatants
from wild type and the abaI::Tc mutants showed that the addition
of ethyl-acetate extracts from the wild type cells restored the ability
of the abaI::Tc mutants to form normal biofilms. But, the ethyl-
acetate extracts from the abaI::Tc mutants failed to restore the
biofilm forming capabilities in the abaI::Tc mutant (Fig. 6B).
Discussion
The current view of biofilm infections leads to the realization
that their effective control will require a concerted effort to
develop therapeutic agents that target the biofilm phenotype and
community signalling–based agents that prevent the formation, or
promote the detachment, of biofilms [29]. Several molecules have
been associated with the coordination of activities of microorgan-
isms within a community. These include AHL, oligopeptides,
amino acids such as glutamate and aspartate, and fatty methyl
esters. It is conceivable that one or more of these molecular signals
may impact biofilm physiology [15,30].
QS is a regulatory mechanism which enables bacteria to make
collective decisions with respect to the expression of a specific set of
genes. These may include genes involved in biofilm formation and
virulence. They play a key role in orchestrating the expression of
exoproteases, siderophores, exotoxins and several secondary
metabolites, and participate in the development of biofilms.
Figure 2. Agar plate assays for screening the production of acylated homoserine lactone (AHL) in Acinetobacter spp. clinical isolates
using Chromobacterium violaceum CV026 (Inhibition) as monitor system. All the seven isolates that tested positive for long-chain AHLs are
shown.
doi:10.1371/journal.pone.0036696.g002
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It has been shown that in contrast to the other QS systems, the
AHL-mediated QS signalling system appears to control genes
essential for colonisation of eukaryotes across a large number of
bacterial species. This process is facilitated by bacterial biofilms
[29]. The high density of bacteria within biofilms has led to the
speculation that quorum-sensing genes and AHL production may
be fundamentally associated with biofilm physiology. It has been
shown that mutations in autoinducer synthesis lead to the
formation of biofilms with abnormal structures in Acinetobacter
baumannii [27].
In our study, it is observed that about 60% of our clinical
isolates of Acinetobacter spp. significantly formed biofilms under
prolonged period of incubation. When investigations on the
sources of isolation of these isolates were done, they were equally
from the upper and lower respiratory tracts. All these isolates were
also screened for the QS signal molecule production and 7 of these
isolates effectively produced long chain AHL molecules by using
the CV026 biosensor monitor system. On analysis of the biofilm
forming capabilities of the 7 isolates that produced the long chain
AHls, they all form biofilms significantly. The method presented
here for screening pure cultures of Acinetobacter spp. for AHL
production using the Chromobacterium violaceum CV026 monitor
system has not been used previously. It is rapid and does not
require sterile supernatants or AHL extractions from cultures. It
also has the advantages of only requiring monitor strains and the
ability of the strains tested to grow on LB media. Also about 6
strains can be tested on the same plate. The only limitation of this
assay is that the detection limit lies within the scope of the signal
monitor system CV026 that was used and this monitor system is
poor in sensing some of the signal molecules.
In this study, it has been shown that among the 30 biofilm
forming isolates, only 7 produced long-chain AHLs. This may be
due to the fact that biofilm formation is a multifactorial event and
QS signals are one of such factors. Genetic analysis of biofilm
formation has led to the proposal that extracellular signals and
quorum sensing regulatory systems are essential for differentiated
biofilms. Hence, differentiated biofilms may also be the net result
of many independent interactions, rather than being determined
by a particular global Quorum Sensing system [31].
Further mass spectrometric analysis confirmed the presence of
C10 AHLs in the tested 5 isolates and other 2 isolates produced
AHLs with chain lengths C12. Of the masses that were reported
Figure 3. (A) Chromobacterium violaceum CV026 well-diffusion assay in LB agar. N-hexanoyl homoserine lactone (HHL) was added to wells in
agar containing Chromobacterium violaceum CV026. Zones of HHL-induced violacin production is seen surrounding the wells. Increasing
concentration of AHL shows the increase in zone diameters. Standard curve showing the relationship between concentration of acylated homoserine
lactone (N-hexanoyl homoserine lactone (HHL) & N-Decanoyl homoserine lactone (DHL)) and resulting diameters of induced/inhibited zones in
Chromobacterium violaceum CV026 monitor system. (B) Well-diffusion assay for the tested isolates. Extraction efficiencies were tested on supernatants
from Acinetobacter strains. Yields obtained were in the range of 161029 moles to 661029 moles of AHLs.
doi:10.1371/journal.pone.0036696.g003
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the only ones that seem to make sense are 284 and 282 as an AHL
with a 12 carbon acyl chain, with the lower mass (282) containing
a single alkene (Table 1). An alkene could be anywhere along the
chain length, however it can be rationalized that it could be a
dehydration product from a beta-hydroxy derivative. The
retention time at a later time than the decanoyl standard fits well.
These masses were found in samples 53 and 102. In Table 1, it is
shown that some strains produce a signal with an m/z of 274 that
gives rise to a MS/MS product of 102 suggesting it is likely
comprised of an HSL moiety. This could be due to the presence of
minor quantity of 3-oxo- C11 HSLs. However, none of the clinical
isolates tested produced 3-OH-C12 seen in the M2 strain
described by Niu et al [27].
Further quantification of the QS molecules by well diffusion
assay revealed that a minimum of approximately 261029 moles
and a maximum of 661029 moles of AHLs were detected among
the clinical isolates of Acinetobacter. Quantifications done by mass
spectrometric analysis also confirms these values.
An autoinducer synthase gene in A. baumannii that was
designated as abaI has already been identified and characterised.
The deduced AbaI protein was highly similar to the members of
the LuxI family. It has been shown that this autoinducer
synthase was required for normal biofilm development [27]. In
our study we have identified and analysed abaI gene which
encodes a similar protein. The BLAST analysis revealed that
the abaI protein has only 91% identity with the already reported
protein, but still retains its function as a quorum sensing
autoinducer synthase. Further, the similarity of the identified
AbaI protein from S117 to various species of Burkholderia,
Pseudomonas fluorescens and Acidithiobacillus ferrooxidans suggests a
common origin of these genes.
In this study we have further cloned the abaI gene. The cloned
gene was further mutated and a abaI::Tc mutant of the gene was
created and the mutant was shown to have inhibition in the
biofilm formation. This shows that the abaI gene product was
required for biofilm formation (Fig. 6). The differences between
the wild type and the abaI::Tc mutant clearly showed that abaI
directed AHL pathway is required for efficient biofilm formation.
The mutation complementation experiments reveal that the wild
type phenotype can be restored.
This study has revealed that it is likely that QS regulation is
important for biofilm development, but there is no reason to
assume that this type of regulation is the only important effector.
In a given setting, the biofilm associated community will exploit all
available adaptive mechanisms and the corresponding network of
regulatory activities (including QS) and it is not possible to
unequivocally assign a specific determining regulatory factor for
the structure/function relationship of the community.
Figure 4. MS profiles of AHL signals. An Agilent 6520 LC-ESI-QTOF in full scanning positive ion mode or auto-MS/MS mode in a range of 50–
1600 m/z was used. TIC trace of each sample (1, 11, 53, 54, 93, 102, 117) with overlaid common precursor ions are respectively shown in figures 1, 2, 3,
4, 5, 6 and 7. Each of the peaks was then analyzed by MS to identify the parent ion, and the full MS profile for each ion was established to identify the
exact chain lengths of the AHLs.
doi:10.1371/journal.pone.0036696.g004
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In conclusion, the use of simple methods for detection of AHLs
and their involvement in biofilm formation have been presented.
These methods can be used to determine to certain extent the type
of AHLs produced as well as to study the increase in AHL
concentration over time. Mass spectrometric analysis revealed the
exact structure of these AHL molecules to be C10 and C12.
The identification of the abaI and the AHL signals will allow the
identification of the antagonists that inhibit biofilm development.
These antagonists may reduce the ability of Acinetobacter spp. to
survive on environmental surfaces for extended periods, a key
component of its ability to form biofilms and persistence in
intensive care wards.
Materials and Methods
Bacterial Strains and Culture Conditions
Fifty strains that were identified as Acinetobacter spp. were
obtained from the Diagnostic Bacteriology Laboratory, University
Malaya Medical Centre (UMMC) between August 2003 to March
2004. The strains were obtained from invasive and non-invasive
sites which include blood, tracheal secretion, sputum, throat swab,
peritoneal fluid, wound, bronchial lavage, and urine. The details
of the source of isolation of all these isolates have been listed
(Table 2). The identity of the isolates was confirmed using
standard laboratory methods which include Gram-stain, colony
morphology, lactose fermention, and reaction to the oxidase test
[32]. The isolates were further reconfirmed to belong to the
Acinetobacter baumannii/calcoaceticus complex using API20NE kit
(bioMerieux, France). These isolates were all screened for the
production of quorum sensing signal molecules. The test isolates
were grown on LB (Difco).
The biosensor strains detect AHL signals by the activation of a
reporter gene such as lacZ or lux or by the production of or
inhibition of a purple pigment in Chromobacterium violaceum.
Table 1. Observed precursors displaying fragments
corresponding to 102.1, 74.1 and 71.1.
Sample Compound Mass
Retention
time (min) Fragments
1 1 274.7 4.94 102.1
274.7 4.94 74.1
274.6 4.94 71.1
2 256.7 5.59 102.1
256.7 5.59 74.1
256.7 5.59 71.1
3 256.7 7.51 102.1
11 1 317.6 1.36 102.1
2 274.7 4.92 102.1
274.8 74.1
274.8 71.1
3 256.6 5.57 102.1
256.7 74.1
256.7 71.1
53 1 317.7 1.45 102.1
2 212.6 2.37 71.1
3 246.6 3.02 71.1
4 471.1 4.34 102.1
5 274.8 4.85 102.1
274.7 71.1
6 318.8 4.99 74.1
7 300.1 5.51 74.1
8 256.9 7.54 74.1
256.7 102.1
256.8 71.1
9 282.8 7.68 71.1
10 284.6 8.23 102.1
54 1 274.7 4.59 102.1
274.8 74.1
274.8 71.1
2 256.8 5.26 74.1
256.8 5.26 71.1
256.8 5.26 102.1
Sample Compound Mass Retention time
(min)
Fragments
93 1 274.7 4.59 102.1
274.7 71.1
274.7 74.1
2 256.7 5.58 102.1
256.7 71.1
256.7 74.1
3 256.6 7.51 74.1
102 1 317.6 1.4 102.1
2 212.5 1.93 71.1
3 212.5 2.39 71.1
4 246.7 3.04 71.1
5 274.8 4.83 102.1
Table 1. Cont.
Sample Compound Mass
Retention
time (min) Fragments
6 318.8 4.98 74.1
7 301 5.58 74.1
8 363.1 5.79 102.1
9 256.8 7.52 71.1
256.8 102.1
256.8 74.1
10 284.7 8.16 102.1
284.6 74.1
284.9 71.1
117 1 274.7 4.92 71.1
274.8 74.1
274.7 102.1
2 256.7 5.61 71.1
256.7 74.1
256.7 102.1
3 256.7 7.52 71.1
256.7 74.1
256.7 102.1
doi:10.1371/journal.pone.0036696.t001
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Chromobacterium violaceum, a Gram-negative bacterium commonly
found in soil and water, produces the characteristic purple
pigment violacein. Previously the authors described a violacein-
negative, mini-Tn5 mutant of Chromobacterium violaceum (CV026) in
which pigment production can be restored by incubation with
supernatants from the wild-type strain. This mutant was developed
to be used as a general biosensor for AHLs. In CV026, violacein is
inducible by all the AHL compounds evaluated with N-acyl side
chains from C4 to C8 in length, with varying degrees of sensitivity.
Although AHL compounds with N-acyl side chains from C10 to
C14 are unable to induce violacein production, if an activating
AHL is incorporated into the agar, these long-chain AHLs can be
detected by their ability to inhibit violacein production. Chromo-
bacterium violaceum strain CV026 was the monitor strain used to
screen for AHL-producing Acinetobacter strains. The CviR (Chromo-
bacterium violaceum Repressor) of Chromobacterium violaceum strain
CV026 (Throup et al., 1995) [33] regulates the production of a
purple pigment when induced by AHL. Certain long-chained
AHLs reversibly inhibit the induced CviR resulting in a lack of
pigment when compared to a control. The CV026 strain was
routinely grown in a shaker incubator in Luria Bertani broth (LB)
(1% peptone, 0.5% yeast extract, 0.5% NaCl; PH 7.00) (Bertani,
1951) [34] solidified with 1.25% agar when required and
supplemented with 20 mg/ml of kanamycin. For screening AHLs,
TY medium containing (per liter) 8 g of Bacto Tryptone (Difco
Laboratories), 5 g of yeast extract, and 5 g of NaCl (pH 7) was
used.
Quantification of Biofilm Formation Using Microtiter
Plate Method
Biofilm formation was determined by the ability of cells to
adhere to the base of 96-well polystyrene plate using the method of
Boddey et al [35] with modification. Briefly, 100ml of LB broth was
added into each well of sterile 96-well polystyrene plate followed
by the addition of 1ml of bacterial culture that was grown at 37uC
overnight with shaking at 150 rpm. The plate was incubated
without shaking at 37uC for 18 hours. Thereafter, 1 ml from each
well was transferred into triplicate wells of a fresh 96-well plate
containing 100 ml of fresh LB and the plates incubated without
shaking for 24 hours at 37uC. Following incubation the
supernatant was discarded carefully and the wells were stained
with 150ml of 1% crystal violet at room temperature for 30
minutes. The stain was then removed and the wells were washed
twice with 175 ml sterile deionized water, before the addition of
175 ml of dimethyl sulfoxide (DMSO) to solubilize the crystal
violet. The plate was then read spectrophotometrically at an
absorbance wavelength of 570 nm. For each strain the assay was
run in triplicate wells and in three independent experiments. Wells
containing only the medium was used as control. The same
protocol was followed to quantify the biofilm after prolonged
incubation at 37uC for 48 hours and then they were compared to
the biofilms formed after incubation for 24 hours.
Statistical Analysis
The significance of the biolfilms formed by the 50 isolates were
statistically analysed by using a one-way analysis of variance
(ANOVA) with post hoc multiple comparisons. The P value was less
than 0.05. All the statistical tests were performed by SPSS
software.
Screening for AHL
Screening for AHL production among the 50 isolates was done
as follows: A fresh plate of C.violaceum CV026 was prepared on LB
agar plates containing 20 mg/ml kanamycin. This plate was
incubated overnight at 37uC. A loopful of cells was taken and
resuspended in 10 ml of sterile water and adjusted to an OD 600 nm
of approximately 0.4. Then 5 ml of this culture was added to
200 ml of cooled TY agar and poured as a thin plate. The test
strains were grown separately in 5 ml of TY broth for 24 hours
and then diluted to an OD 600 nm of 1.0. About 5 ml drops of the
test strains were then added to the previously prepared
chromoplate and allowed to dry. The tests are done in duplicate
and incubated for 2–3 days at 28uC. This test can detect the
presence of short chain AHL producing test strains. For detecting
the long chain AHLs producing test strains a variant of this test
was carried out in which the chromoplate was prepared along with
75 nM concentration of N-Hexanoyl Homoserine lactone (HHL)
incorporated in the medium. Monitor strains themselves served as
negative control and monitor strains in plate containing 75 nM
HHL served as positive control. The basic concept of this method
was adopted from McClean et al 1997 [23]. This method was
previously not used for directly screening AHL producing bacteria.
Figure 5. The electrophoretic banding patterns of the PCR products using the primers for the abaI gene. Lane 1–100bp DNA ladder,
lane 2, 3, 4, 5, 6, 7, 8– amplicons from isolates S1, S11, S53, S54, S93, S102 and S117 respectively, lane 9– Negative control.
doi:10.1371/journal.pone.0036696.g005
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Extraction of Culture Supernatants for Mass
Spectrometry
Extractions for Mass Spectrometry (MS) were prepared as
described by Shaw et al 1997 [24] with minor modifications. Ten-
milliliter volumes of the bacterial cultures were centrifuged and the
supernatants were extracted with an equivalent volume of ethyl
acetate acidified by supplementing with 0.5% formic acid. The
mixture was shaken vigorously for 30 seconds and the two phases
were allowed to separate. The shaking was repeated three times
before the ethyl acetate containing fraction was removed and
another 10 ml fraction was added. The whole extraction process
was repeated three times. The combined extracts were dried
filtered and evaporated to dryness. Residues were dissolved in 50–
100 ml of HPLC–grade ethyl acetate. Comparisons were made of
Figure 6. Biofilm formation of the wild type abaI and abaI::Tc mutant. (A) The microtiter plate was employed to evaluate the biofilm
formation among the wild type abaI and abaI::Tc mutant over time. There is considerable inhibition of biofilm formation in the abaI::Tc mutant
compared to the wild type. (B) Ethyl-acetate (EtAc) extracts of wild type and the abaI::Tc mutant from the culture supernatants were added for the
complementation experiments.
doi:10.1371/journal.pone.0036696.g006
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extraction efficiencies using both acidified and non-acidified ethyl
acetate.
Well-diffusion Assays
Quantifications of the AHLs produced by the test strains can
be done by well-diffusion assays. This was done as described by
Ravn et al 2001 [36] with some modifications. The agar plates
were prepared as follows: a preculture of Chromobacterium
violaceum CV026 was grown in LB for 24 hours at 25uC with
aeration and 2 ml of the preculture was used to inoculate
100 ml of LB broth. The culture was grown for 24 hours at
25uC with aeration and was poured into 200 ml of LB agar
(1.2% agar) containing 20 mg/ml kanamycin maintained at
46uC. The agar culture solution was immediately poured as
20 ml portions in petri dishes. Fifty ml volumes of AHL
containing solutions (either the standard or the extraction from
culture supernatants) were pipetted into wells (6 mm) punched
in the solidified agar. The plates were incubated at 25uC for 48
hours before the diameter of the AHL induced zones
surrounding the wells was measured. For the inhibition of the
induced CV026, the LB-agar was supplemented with 75 nM N-
hexanoyl L-homoserine lactone (HHL, Sigma- Aldrich).
Mass Spectrometry
Extracts were also subjected to Mass Spectrometric analysis.
Sample pellets were re-suspended in a mixture of 50% acetoni-
trile:distilled water 0.1% formic acid (200 mL) initially using a
pipette, then sonicated for several minutes. The samples were
centrifuged for 5 minutes at maximum rpm and then the
supernatant was carefully removed and transferred to a new vial.
10 mL of each sample was transferred to a sample vial with insert
and diluted 1 in 5 by addition of 50% acetonitrile, 0.1% formic
acid (40 mL). An Agilent 6420 LC-ESI-QQQ using a dynamic
multiple reaction monitor (DMRM) was used for quantification.
Instrument conditions were: Gas Temperature: 300uC, Gas Flow:
10.5 L/min, Nebulizer: 45 psi, Capillary (positive): 4000V.
Samples were injected (2mL) and separated by reverse-phase
chromatography on an Agilent Poroshell 120 EC-C18
(2.16100 mm, 2.7 mm, 600 Bar) column, using the following
buffers (100% water/0.1% FA) and (100% ACN/0.1% FA), with
temperature maintained at 35uC.
The samples were analysed using an Agilent 6520 LC-ESI-
QTOF in full scanning positive ion mode or auto-MS/MS mode
in a range of 50–1600 m/z. Instrument conditions were: Gas
Temperature: 300uC, Gas Flow: 10.5 L/min, Nebulizer: 45 psi,
Capillary (positive): 4000V, Fragmentor: 150V, Skimmer 65V.
Samples were injected in 1 mL volumes and separated by reverse-
phase chromatography on an Agilent Poroshell 120 EC-C18
(2.16100 mm, 2.7 mm, 600 Bar) column, using the following
buffers (100% water/0.1% FA) and (100% ACN/0.1% FA), with
temperature maintained at 35uC.
MS/MS Spectra were collected using the following parameters:
MS (Full scan) range: 100–1600 m/z collected at a rate of 1
spectra/s. Auto MS/MS range: 50–1600 m/z collected at rate of 3
Table 2. Strain number, patient number, ward, source and
date of isolation of 50 Acinetobacter spp. isolates.
No. Patient No. Date Collected Ward Source
1 1106728 29/08/2003 ICU Tracheal aspiration
11 1147833 03/12/2003 8U Tracheal
49 1163189 07/01/2004 13U Sputum
99 1176996 09/02/2004 13U Sputum
9 11464697 01/12/2003 6TE Tracheal secretion
21 1152147 12/12/2003 ICU Tracheal secretion
93 1170717 25/01/2004 ICU Tracheal secretion
102 1179797 14/02/2004 7U Wound swab
3 1133309 28/10/2003 6TD Blood-PICC
4 1137968 07/11/2003 6TD Blood C+S
8 1146957 02/12/2003 P2 Blood
70 1166501 14/01/2004 P5 Throat swab
113 1186526 01/03/2004 8D Throat swab
117 1188198 04/03/2004 ICU BAL
6 1147974 04/12/2003 6U Tracheal secretion
12 1149607 08/12/2003 CICU Tracheal secretion
13 1149580 08/12/2003 8D Wound swab
14 1149626 08/12/2003 ICU Tracheal secretion
15 1150413 09/12/2003 ICU Tracheal secretion
22 1151037 10/12/2003 CICU Wound swab
26 1155939 21/12/2003 P1 Peritoneal fluid
29 1157633 24/12/2003 ICU Tip for epidermal catheter
30 1156504 22/12/2003 ICU Tracheal Secretion
33 1157503 24/12/2003 7U BAL
35 1157917 26/12/2003 6U Tracheal secretion
45 1159599 30/12/2003 6U Abrasion over back
46 1160751 01/01/2004 ICU Tracheal secretion
48 1163171 07/01/2004 7U Tracheal secretion
52 1162203 05/01/2004 7U Sputum
53 1161971 05/01/2004 8U Suture line swab
54 1164238 09/01/2004 P5 Urine
55 1161540 03/01/2004 6U Wound swab
57 1164572 09/01/2004 6U Tracheal secretion
59 1165166 11/01/2004 7U Bronchial lavage
61 1162426 06/01/2004 ICU Tracheal secretion
62 1161661 04/01/2004 13U Tracheal secretion
63 1162120 05/01/2004 P1 Bronchial lavage
69 1167282 15/01/2004 7U Tracheal secretion
73 1168513 18/01/2004 7U Bronchial 3 plugged &
mucous
77 1167614 15/01/2004 ICU Peritoneal fluid
80 1171825 27/01/2004 13U Tracheal secretion
81 1171359 26/01/2004 13U Swab & foot pressure sore
90 1171487 26/01/2004 ICU Tracheal secretion
94 1176566 08/02/2004 6U Pus swab
96 1176799 09/02/2004 7D Wound Swab
104 1177833 10/02/2004 ICU Double lumen tips
107 1180637 16/02/2004 12U Wound swab
114 1186122 28/02/2004 12U Sputum
Table 2. Cont.
No. Patient No. Date Collected Ward Source
124 1184548 25/02/2004 13U Tracheal aspiration
125 1185678 26/02/2004 ICU Tracheal secretion
doi:10.1371/journal.pone.0036696.t002
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spectra/s with a maximum of 5 precursors selected and
fragmented using collision energy of 25V. Precursors were
excluded after 1 spectra for a period of 30 seconds.
The standards of beta-ketocaproyl, hexanoyl, heptanoyl,
octanoyl and decanoyl were diluted using 100% acetonitrile.
The diluted standards were mixed to provide a stock solution
containing all standards with the following concentrations: 0.1,
0.5, 1, 5, 10, 50, 100, 500, 1000, 5000 and 10,000 micromolar
(mM). A standard curve was run between the concentrations and in
each case a curve was fit over the appropriate range, with a linear
curve attempted in all cases, except where high concentration
points were required. For the experiment where concentrated
samples were tested a limited concentration range 0.1 mM –
100 mM was used, this significantly reduced signal suppression and
turnover of the standard curve. Quantification of AHLs in the
sample was done using these standard curves.
Identification of abaI Gene in Acinetobacter spp.
Producing the QS Signal Molecules
The presence of abaI gene encoding an autoinducer synthase
was identified by polymerase chain reaction (PCR) using already
published primers [27], F-59-GTACAGTCGACGTATTTGTT-
GAATATTTGGG-39 and R-59-CGTACGTCTAGAGTAAT-
GAGTTGTTTTGCGCC-39. The final PCR amplification reac-
tion mixture contained 5.0 mM PCR buffer, 8.3 mM MgCl2,
200 nM dNTP (MBI, Fermentas, Vilnius, Lithuania), 0.3 mM of
each primer pair, 2 units of Taq DNA polymerase (MBI,
Fermentas) and 3 ml of DNA template in a final volume of
25 ml. The PCR amplification was performed with mycyler
thermocycler (BioRad laboratires, Hercules, CA) with the
following PCR temperature cycling parameters: Initial denatur-
ation at 94uC for 10 minutes followed by 30 cycles of denaturation
at 94uC for 30 seconds, Primer annealing at 66.5uC for 30
seconds, primer extension at 72uC for 1 minute and the final
extension at 72uC for 5 minutes. The resulting amplicons of the
isolate S117 has been sequenced and it’s organisation in the
genome was analysed.
Mutation in the abaI Gene
The abaI gene from isolate S117 was further cloned into plasmid
vector pCR 2.1-TOPO using the TOPO TA cloning kit
(Invitrogen Corporation, California) following the manufacturer’s
instructions. The PCR purification of the abaI gene was done using
the Expin PCR purification kit (GeneAll Biotechnology, Korea)
before cloning. The cloned abaI gene was disrupted by insertional
inactivation using tetracycline gene cassette at the SspI site (blunt
end ligation) within the abaI gene. The insertion of tetracycline
gene in the coding region of the abaI gene that prevented the
production of the AHL signal was identified using the biosensor
strain. To inactivate the abaI gene in the chromosome of the
Acinetobacter spp. S117, the insertion that disrupted the abaI gene in
the middle along with the flanking chromosomal DNA was cloned
into pUC18- based suicide delivery vector. This plasmid
pUC18.abaI::Tc was introduced into Acinetobacter spp. S117 by
conjugation. E.coli K12 carrying the pUC18.abaI::Tc plasmid was
the donor. Matings were performed on filter membrane. Following
conjugation, the suicide vector pUC18.abaI::Tc would be
integrated at the wildtype abaI gene, that results in the wildtype
copy of the abaI gene and second copy with the abaI::Tc
disruption. These exconjugants with both the wildtype and the
mutant copy of the abaI gene (single crossover event) were selected
based on their tetracycline and ampicillin resistance (tetracycline
marker was present on the disrupted abaI gene and ampicillin
marker was on the pUC18 vector). Following this, the exconju-
gants were grown without the antibiotic pressure. This removes
the pressure to maintain the plasmid integration. Then the
exconjugants that carry only the mutant abaI gene (double
crossover event) were selected by eliminating any bacteria that
have maintained the plasmid integration and selecting the bacteria
that does not grow in the presence of the vector marker
(ampicillin). The mutation was confirmed by PCR to get wildtype
PCR products followed by sequencing. The abaI::Tc mutants
failed to produce any AHL signals and were further evaluated for
their biofilm forming capabilities and compared with the biofilm
formation in the wild type abaI gene. The biofilm formation was
done as described previously in microtiter plate. To demonstrate
that the biofilm inhibition in the mutant was due to the loss of the
AHL signal, mutation complementation experiment with the
exogenously added AHLs as the ethyl-acetate extracts of the
culture supernatants from the wildtype and the mutants was
performed. Only ethyl-acetate was added in the negative control
samples.
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